NAVB logo

NAVB Cash From Investing

Annual CFI

-$390.30 K
-$60.90 K-18.49%

December 31, 2022


Summary


Performance

NAVB Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBcash flowmetrics:

Quarterly CFI

-$524.70 K
-$459.70 K-707.23%

September 30, 2023


Summary


Performance

NAVB Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBcash flowmetrics:

TTM CFI

-$701.10 K
-$445.80 K-174.62%

September 30, 2023


Summary


Performance

NAVB TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NAVB Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.5%-707.2%-174.6%
3 y3 years-150.7%-707.2%-174.6%
5 y5 years+78.7%-707.2%-174.6%

NAVB Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.5%at low-1231.7%at low-174.6%at low
5 y5-year-150.7%+5.5%-1235.1%at low-191.0%at low
alltimeall time-101.4%+97.6%-101.9%+94.2%-102.6%+95.7%

Navidea Biopharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2023
-
-$524.70 K(+707.2%)
-$701.10 K(+174.6%)
Jun 2023
-
-$65.00 K(+65.0%)
-$255.30 K(-18.0%)
Mar 2023
-
-$39.40 K(-45.3%)
-$311.50 K(-20.2%)
Dec 2022
-$390.30 K(+18.5%)
-$72.00 K(-8.7%)
-$390.30 K(-4.3%)
Sep 2022
-
-$78.90 K(-34.9%)
-$407.70 K(-11.8%)
Jun 2022
-
-$121.20 K(+2.5%)
-$462.00 K(+21.5%)
Mar 2022
-
-$118.20 K(+32.2%)
-$380.10 K(+15.4%)
Dec 2021
-$329.40 K(-20.2%)
-$89.40 K(-32.9%)
-$329.40 K(+2.1%)
Sep 2021
-
-$133.20 K(+238.9%)
-$322.60 K(-18.5%)
Jun 2021
-
-$39.30 K(-41.8%)
-$396.00 K(-4.8%)
Mar 2021
-
-$67.50 K(-18.3%)
-$415.90 K(+0.8%)
Dec 2020
-$412.80 K(-153.6%)
-$82.60 K(-60.0%)
-$412.80 K(+6.3%)
Sep 2020
-
-$206.60 K(+249.0%)
-$388.20 K(-2050.8%)
Jun 2020
-
-$59.20 K(-8.1%)
$19.90 K(-95.8%)
Mar 2020
-
-$64.40 K(+11.0%)
$479.10 K(-37.8%)
Dec 2019
$770.40 K(-19.2%)
-$58.00 K(-128.8%)
$770.40 K(-3.9%)
Sep 2019
-
$201.50 K(-49.6%)
$801.50 K(+37.3%)
Jun 2019
-
$400.00 K(+76.3%)
$583.80 K(-25.2%)
Mar 2019
-
$226.90 K(-943.5%)
$780.60 K(-18.2%)
Dec 2018
$953.80 K(-152.0%)
-$26.90 K(+66.0%)
$953.70 K(-19.1%)
Sep 2018
-
-$16.20 K(-102.7%)
$1.18 M(+0.6%)
Jun 2018
-
$596.80 K(+49.2%)
$1.17 M(-181.7%)
Mar 2018
-
$400.00 K(+102.3%)
-$1.43 M(-21.8%)
Dec 2017
-$1.83 M(+4577.8%)
$197.70 K(-952.2%)
-$1.83 M(-9.7%)
Sep 2017
-
-$23.20 K(-98.8%)
-$2.03 M(+1.2%)
Jun 2017
-
-$2.01 M(<-9900.0%)
-$2.01 M(+5269.5%)
Mar 2017
-
$0.00(0.0%)
-$37.40 K(-4.6%)
Dec 2016
-$39.20 K(+41.0%)
$0.00(0.0%)
-$39.20 K(-18.0%)
Sep 2016
-
$0.00(-100.0%)
-$47.80 K(-3.8%)
Jun 2016
-
-$37.40 K(+1977.8%)
-$49.70 K(+12.2%)
Mar 2016
-
-$1800.00(-79.1%)
-$44.30 K(+59.4%)
Dec 2015
-$27.80 K(-98.2%)
-$8600.00(+352.6%)
-$27.80 K(-41.5%)
Sep 2015
-
-$1900.00(-94.1%)
-$47.50 K(-88.7%)
Jun 2015
-
-$32.00 K(-317.7%)
-$419.70 K(-18.9%)
Mar 2015
-
$14.70 K(-151.9%)
-$517.60 K(-66.1%)
Dec 2014
-$1.52 M(+18.0%)
-$28.30 K(-92.4%)
-$1.52 M(-23.7%)
Sep 2014
-
-$374.10 K(+188.0%)
-$2.00 M(+15.8%)
Jun 2014
-
-$129.90 K(-86.9%)
-$1.73 M(-10.5%)
Mar 2014
-
-$992.60 K(+98.0%)
-$1.93 M(+49.2%)
Dec 2013
-$1.29 M(+92.4%)
-$501.20 K(+390.4%)
-$1.29 M(+54.0%)
Sep 2013
-
-$102.20 K(-69.2%)
-$839.30 K(-14.6%)
Jun 2013
-
-$332.10 K(-6.9%)
-$982.60 K(+10.8%)
Mar 2013
-
-$356.90 K(+642.0%)
-$887.20 K(+32.1%)
Dec 2012
-$671.80 K(-102.5%)
-$48.10 K(-80.4%)
-$671.70 K(+20.7%)
Sep 2012
-
-$245.50 K(+3.7%)
-$556.60 K(-102.1%)
Jun 2012
-
-$236.70 K(+67.4%)
$26.86 M(-0.8%)
Mar 2012
-
-$141.40 K(-311.0%)
$27.08 M(-0.3%)
Dec 2011
$27.16 M(-6911.7%)
$67.00 K(-99.8%)
$27.16 M(+0.4%)
Sep 2011
-
$27.17 M(<-9900.0%)
$27.06 M(<-9900.0%)
Jun 2011
-
-$22.10 K(-63.9%)
-$216.20 K(-39.4%)
Mar 2011
-
-$61.30 K(+88.6%)
-$356.80 K(-10.5%)
Dec 2010
-$398.70 K(-222.1%)
-$32.50 K(-67.6%)
-$398.80 K(+1.5%)
Sep 2010
-
-$100.30 K(-38.4%)
-$393.10 K(+25.2%)
Jun 2010
-
-$162.70 K(+57.5%)
-$314.10 K(+44.1%)
Mar 2010
-
-$103.30 K(+285.4%)
-$217.90 K(-166.7%)
Dec 2009
$326.60 K(-152.1%)
-$26.80 K(+25.8%)
$326.50 K(-300.4%)
Sep 2009
-
-$21.30 K(-68.0%)
-$162.90 K(+4990.6%)
Jun 2009
-
-$66.50 K(-115.1%)
-$3200.00(-98.1%)
Mar 2009
-
$441.10 K(-185.5%)
-$170.40 K(-72.8%)
Dec 2008
-$627.30 K
-$516.20 K(-473.0%)
-$627.40 K(+439.0%)
Sep 2008
-
$138.40 K(-159.2%)
-$116.40 K(-55.1%)
DateAnnualQuarterlyTTM
Jun 2008
-
-$233.70 K(+1369.8%)
-$259.50 K(+658.8%)
Mar 2008
-
-$15.90 K(+205.8%)
-$34.20 K(-28.6%)
Dec 2007
-$48.00 K(-103.5%)
-$5200.00(+10.6%)
-$47.90 K(-60.0%)
Sep 2007
-
-$4700.00(-44.0%)
-$119.70 K(-29.3%)
Jun 2007
-
-$8400.00(-71.6%)
-$169.30 K(+39.5%)
Mar 2007
-
-$29.60 K(-61.6%)
-$121.40 K(-108.9%)
Dec 2006
$1.36 M(-183.6%)
-$77.00 K(+41.8%)
$1.36 M(-59.6%)
Sep 2006
-
-$54.30 K(-237.5%)
$3.37 M(-18.9%)
Jun 2006
-
$39.50 K(-97.3%)
$4.15 M(+23.9%)
Mar 2006
-
$1.45 M(-24.8%)
$3.35 M(-306.1%)
Dec 2005
-$1.63 M(+1369.1%)
$1.93 M(+164.3%)
-$1.63 M(-54.6%)
Sep 2005
-
$730.90 K(-196.0%)
-$3.58 M(-17.5%)
Jun 2005
-
-$761.70 K(-78.4%)
-$4.34 M(+20.2%)
Mar 2005
-
-$3.53 M(>+9900.0%)
-$3.62 M(+3166.7%)
Dec 2004
-$110.70 K(+1.1%)
-$26.30 K(-11.7%)
-$110.70 K(+0.7%)
Sep 2004
-
-$29.80 K(-9.7%)
-$109.90 K(-17.1%)
Jun 2004
-
-$33.00 K(+52.8%)
-$132.50 K(+17.6%)
Mar 2004
-
-$21.60 K(-15.3%)
-$112.70 K(+2.9%)
Dec 2003
-$109.50 K(-65.2%)
-$25.50 K(-51.3%)
-$109.50 K(-108.0%)
Sep 2003
-
-$52.40 K(+297.0%)
$1.37 M(-34.6%)
Jun 2003
-
-$13.20 K(-28.3%)
$2.10 M(-5.3%)
Mar 2003
-
-$18.40 K(-101.3%)
$2.22 M(-803.9%)
Dec 2002
-$314.70 K(-389.8%)
$1.46 M(+116.2%)
-$314.70 K(-80.3%)
Sep 2002
-
$673.30 K(+542.5%)
-$1.60 M(-30.1%)
Jun 2002
-
$104.80 K(-104.1%)
-$2.29 M(-5.5%)
Mar 2002
-
-$2.55 M(-1572.2%)
-$2.42 M(-2329.9%)
Dec 2001
$108.60 K(-92.3%)
$173.10 K(-1246.4%)
$108.50 K(-195.9%)
Sep 2001
-
-$15.10 K(-47.9%)
-$113.10 K(-21.8%)
Jun 2001
-
-$29.00 K(+41.5%)
-$144.60 K(+43.0%)
Mar 2001
-
-$20.50 K(-57.7%)
-$101.10 K(-107.2%)
Dec 2000
$1.40 M(+278.9%)
-$48.50 K(+4.1%)
$1.40 M(-3.3%)
Sep 2000
-
-$46.60 K(-421.4%)
$1.45 M(-3.1%)
Jun 2000
-
$14.50 K(-99.0%)
$1.50 M(+1.0%)
Mar 2000
-
$1.48 M(>+9900.0%)
$1.48 M(-55.1%)
Dec 1999
$369.90 K(-96.5%)
-
-
Jun 1999
-
$0.00(-100.0%)
$3.30 M(-53.5%)
Mar 1999
-
$400.00 K(+0.3%)
$7.10 M(-33.0%)
Dec 1998
$10.60 M(+4199.8%)
$398.90 K(-84.0%)
$10.60 M(+50.4%)
Sep 1998
-
$2.50 M(-34.2%)
$7.05 M(0.0%)
Jun 1998
-
$3.80 M(-2.6%)
$7.05 M(+989.9%)
Mar 1998
-
$3.90 M(-223.7%)
$646.50 K(+162.3%)
Dec 1997
$246.50 K(-101.5%)
-$3.15 M(-226.1%)
$246.50 K(-107.7%)
Sep 1997
-
$2.50 M(-196.2%)
-$3.20 M(-60.0%)
Jun 1997
-
-$2.60 M(-174.3%)
-$8.00 M(-44.4%)
Mar 1997
-
$3.50 M(-153.0%)
-$14.40 M(-11.1%)
Dec 1996
-$16.20 M(+165.6%)
-$6.60 M(+187.0%)
-$16.20 M(+78.0%)
Sep 1996
-
-$2.30 M(-74.4%)
-$9.10 M(-30.5%)
Jun 1996
-
-$9.00 M(-629.4%)
-$13.10 M(+118.3%)
Mar 1996
-
$1.70 M(+240.0%)
-$6.00 M(-1.6%)
Dec 1995
-$6.10 M(0.0%)
$500.00 K(-107.9%)
-$6.10 M(-60.4%)
Sep 1995
-
-$6.30 M(+231.6%)
-$15.40 M(+102.6%)
Jun 1995
-
-$1.90 M(-218.8%)
-$7.60 M(+153.3%)
Mar 1995
-
$1.60 M(-118.2%)
-$3.00 M(-50.8%)
Dec 1994
-$6.10 M(+408.3%)
-$8.80 M(-686.7%)
-$6.10 M(-229.8%)
Sep 1994
-
$1.50 M(-44.4%)
$4.70 M(-2.1%)
Jun 1994
-
$2.70 M(-280.0%)
$4.80 M(+1100.0%)
Mar 1994
-
-$1.50 M(-175.0%)
$400.00 K(-133.3%)
Dec 1993
-$1.20 M(-66.7%)
$2.00 M(+25.0%)
-$1.20 M(-62.5%)
Sep 1993
-
$1.60 M(-194.1%)
-$3.20 M(-33.3%)
Jun 1993
-
-$1.70 M(-45.2%)
-$4.80 M(+54.8%)
Mar 1993
-
-$3.10 M
-$3.10 M
Dec 1992
-$3.60 M
-
-

FAQ

  • What is Navidea Biopharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals annual CFI year-on-year change?
  • What is Navidea Biopharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals quarterly CFI year-on-year change?
  • What is Navidea Biopharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals TTM CFI year-on-year change?

What is Navidea Biopharmaceuticals annual cash flow from investing activities?

The current annual CFI of NAVB is -$390.30 K

What is the all time high annual CFI for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high annual cash flow from investing activities is $27.16 M

What is Navidea Biopharmaceuticals annual CFI year-on-year change?

Over the past year, NAVB annual cash flow from investing activities has changed by -$60.90 K (-18.49%)

What is Navidea Biopharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of NAVB is -$524.70 K

What is the all time high quarterly CFI for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high quarterly cash flow from investing activities is $27.17 M

What is Navidea Biopharmaceuticals quarterly CFI year-on-year change?

Over the past year, NAVB quarterly cash flow from investing activities has changed by -$459.70 K (-707.23%)

What is Navidea Biopharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of NAVB is -$701.10 K

What is the all time high TTM CFI for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high TTM cash flow from investing activities is $27.16 M

What is Navidea Biopharmaceuticals TTM CFI year-on-year change?

Over the past year, NAVB TTM cash flow from investing activities has changed by -$445.80 K (-174.62%)